Development of a Nonviral Gene Delivery Vehicle for Systemic Application
Authors:
- 20 April 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 13 (3) , 630-639
Abstract
Polycation vehicles used for in vitro gene delivery require alteration for successful application in vivo. Modification of polycations by direct grafting of additional components, e.g., poly(ethylene glycol) (PEG), either before or after DNA complexation, tend to interfere with polymer/DNA binding interactions; this is a particular problem for short polycations such as linear, β-cyclodextrin-containing polycations (βCDPs). Here, a new method of βCDP polyplex (polycation/DNA composite structures) modification is presented that exploits the ability to form inclusion complexes between cyclodextrins and adamantane. Surface-PEGylated βCDP polyplexes are formed by self-assembly of the polyplexes with adamantane−PEG conjugates. While unmodified polyplexes rapidly aggregate and precipitate in salt solutions, the PEGylated βCDP polyplexes are stable at conditions of physiological salt concentration. Addition of targeting ligands to the adamantane−PEG conjugates allows for receptor-mediated delivery; galactosylated βCDP-based particles reveal selective targeting to hepatocytes via the asialoglycoprotein receptor. Galactosylated particles transfect hepatoma cells with 10-fold higher efficiency than glucosylated particles (control), but show no preferential transfection in a cell line lacking the asialoglycoprotein receptor. Thus, surface modification of βCDP-based polyplexes through the use of cyclodextrin/adamantane host/guest interactions endows the particles with properties appropriate for systemic application.Keywords
This publication has 10 references indexed in Scilit:
- Systemic circulation of poly(l-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapyBlood, 2001
- ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColloids and Surfaces B: Biointerfaces, 2000
- Biodistribution, Metabolism, and in Vivo Gene Expression of Low Molecular Weight Glycopeptide Polyethylene Glycol Peptide DNA Co‐CondensatesJournal of Pharmaceutical Sciences, 2000
- Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery systemGene Therapy, 2000
- Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI)The Journal of Gene Medicine, 1999
- Polyethylene glycol-grafted poly-l-lysine as polymeric gene carrierJournal of Controlled Release, 1998
- Complexation of Pyrene by Poly(allylamine) with Pendant β-Cyclodextrin Side GroupsThe Journal of Physical Chemistry B, 1998
- Characterization of Vectors for Gene Therapy Formed by Self-Assembly of DNA with Synthetic Block Co-PolymersHuman Gene Therapy, 1996
- A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Cyclodextrin-adamantanecarboxylate inclusion complexes: studies of the variation in cavity sizeThe Journal of Physical Chemistry, 1985